Welcome

Albireo is an independent Swedish biotechnology company, which brings unique translational approaches to develop drugs that fulfil unmet medical needs in the gastrointestinal (GI) area. The team has a broad experience in drug development, primarily in the GI area and has an extensive network in the international scientific and clinical communities.

Latest News

2009-12-17

First patients randomized in CIC study


2009-11-18

Albireo announces positive clinical data on A3309 in patients with chronic idiopathic constipation

Go to news archive


Events

DDW New Orleans May 2010
BIO-Europe Spring 2010, Barcelona
BIO Asia January 2010, Tokyo
J.P. Morgan January 2010, San Francisco
Gastro UEGW/WCOG November 2009, London
BIO-Europe November 2009, Vienna
DDW Chicago June 2009
BioEquity Europe June 2009, Munich